A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)
Clinical trial NCT04009681 · TERMINATED
Trial details
- NCT number
- NCT04009681
- Sponsor
- Synthorx, Inc, a Sanofi company
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-20
- Primary completion
- 2025-12-02
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.